HIN SANG GROUP (INTERNATIONAL) HOLDING CO. LTD.

Hin Sang Group (International) Holding Co. Ltd.

6893

KYG4590V1023

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
0.31 ^HKD	0.00%		-3.12%	-7.46%

Feb. 19	Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary, Effective 19 February 2024	CI
2023	Hin Sang Group Narrows Fiscal H1 Loss	MT

Hin Sang Group (International) Holding Co. Ltd. Appoint Tian Shanshan as A Non-Executive Director with Effect from 1 December 2021

November 22, 2021 at 09:12 am EST

The Board of Hin Sang Group (International) Holding Co. Ltd. announced that the Board has resolved on 22 November 2021 to appoint Ms. Tian Shanshan as a non-executive Director with effect from 1 December 2021.

Latest news about Hin Sang Group (International) Holding Co. Ltd.

Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary, Effective 19 February 2024	Feb. 19	CI
Hin Sang Group Narrows Fiscal H1 Loss	Nov. 30	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 29	CI
Hin Sang's Loss to Narrow in Fiscal H1	Nov. 20	MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Six Months Ended 30 September 2023	Nov. 17	CI
Hin Sang Group's Fiscal Year 2023 Loss Widens Four Times	23-06-29	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-29	CI
Hin Sang Excepts Loss to Widen for Fiscal Year 2023	23-06-26	MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Financial Year Ended 31 March 2023	23-06-23	CI
Hin Sang Group’s April-Sept Loss Widens as Revenue Falls 4%	22-11-29	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-29	CI
Hin Sang Group (International) Holding Co. Ltd. Auditor Raises 'Going Concern' Doubt	22-07-27	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Management Changes, Effective 1 July 2022	22-06-30	CI
Hin Sang Group Logs $1.7 Million Net Loss in FY22	22-06-29	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-28	CI
Hin Sang Expects Decrease in FY22 Net Loss; Shares Climb 3%	22-06-24	MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Year Ended 31 March 2022	22-06-23	CI
Hin Sang Group Unit Ties Up with Hongli Homologous Biotechnology to Open Chain Stores in China	21-12-30	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-22	CI
Hin Sang Group (International) Holding Co. Ltd. Appoint Tian Shanshan as A Non-Executive Director with Effect from 1 December 2021	21-11-22	CI
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Six Months Ended September 30, 2021	21-11-12	CI
Hin Sang Group (International) Holding Co. Ltd. Announces the Retirement of Yuen Chi Ping as Non-Executive Director	21-09-29	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary	21-08-02	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Unaudited Consolidated Earnings Results for the Year Ended 31 March 2021	21-07-29	CI
Hin Sang International : Group FY21 Loss Swells, Revenue Falls	21-06-25	MT

Chart Hin Sang Group (International) Holding Co. Ltd.

Duration

Period

Chart Hin Sang Group (International) Holding Co. Ltd.

More charts

Company Profile

Hin Sang Group (International) Holding Co. Ltd. is an investment holding company principally engaged in development, marketing and sales of care products, healthcare products and household products under various brands. The Company operates its business through three segments. The Product Development segment is engaged in the sales of products developed by the Company under own brands. The Brand Development and Management segment is engaged in the sales and distribution of products with exclusive distribution rights. The Trading of Goods segment is engaged in the sales and distribution of products purchased from authorized dealers, independent traders, manufacturers and parallel importers.

Sector

Pharmaceuticals

Calendar

2024-06-24 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HIN SANG GROUP (INTERNATIONAL) HOLDING CO. LTD.	-7.46%	43.24M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B